Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin

Autor: Na Yin, Marvin Lin, Stephan Segerer, Barbara Murphy, Bernd Schröppel, M. Edward Medof, Peter S. Heeger
Přispěvatelé: University of Zurich, Schröppel, B
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Blood Glucose
Male
10017 Institute of Anatomy
Endocrinology
Diabetes and Metabolism

T-Lymphocytes
Islets of Langerhans Transplantation
Bone Marrow Cells
610 Medicine & health
medicine.disease_cause
Lymphocyte Activation
Polymerase Chain Reaction
Streptozocin
Autoimmunity
Diabetes Mellitus
Experimental

03 medical and health sciences
Mice
0302 clinical medicine
Immune system
Diabetes mellitus
Internal Medicine
medicine
Animals
Genetic Predisposition to Disease
10035 Clinic for Nephrology
030304 developmental biology
Mice
Knockout

0303 health sciences
business.industry
Reverse Transcriptase Polymerase Chain Reaction
Complement C3
Streptozotocin
medicine.disease
3. Good health
Complement system
2712 Endocrinology
Diabetes and Metabolism

medicine.anatomical_structure
Diabetes Mellitus
Type 1

2724 Internal Medicine
Immunology
Alternative complement pathway
570 Life sciences
biology
Bone marrow
Immunology and Transplantation
business
Insulitis
030215 immunology
medicine.drug
Zdroj: Diabetes
ISSN: 1939-327X
0012-1797
Popis: OBJECTIVE The complement system contributes to autoimmune injury, but its involvement in promoting the development of autoimmune diabetes is unknown. In this study, our goal was to ascertain the role of complement C3 in autoimmune diabetes. RESEARCH DESIGN AND METHODS Susceptibility to diabetes development after multiple low-dose streptozotocin treatment in wild-type (WT) and C3-deficient mice was analyzed. Bone marrow chimeras, luminex, and quantitative reverse transcription PCR assays were performed to evaluate the phenotypic and immunologic impact of C3 in the development of this diabetes model. RESULTS Coincident with the induced elevations in blood glucose levels, we documented alternative pathway complement component gene expression within the islets of the diabetic WT mice. When we repeated the experiments with C3-deficient mice, we observed complete resistance to disease, as assessed by the absence of histologic insulitis and the absence of T-cell reactivity to islet antigens. Studies of WT chimeras bearing C3-deficient bone marrow cells showed that bone marrow cell–derived C3, and not serum C3, is involved in the induction of diabetes in this model. CONCLUSIONS The data reveal a key role for immune cell–derived C3 in the pathogenesis of murine multiple low-dose streptozotocin-induced diabetes and support the concept that immune cell mediated diabetes is in part complement-dependent.
Databáze: OpenAIRE